AU2012283449B2 - Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine - Google Patents

Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine Download PDF

Info

Publication number
AU2012283449B2
AU2012283449B2 AU2012283449A AU2012283449A AU2012283449B2 AU 2012283449 B2 AU2012283449 B2 AU 2012283449B2 AU 2012283449 A AU2012283449 A AU 2012283449A AU 2012283449 A AU2012283449 A AU 2012283449A AU 2012283449 B2 AU2012283449 B2 AU 2012283449B2
Authority
AU
Australia
Prior art keywords
crystalline form
pyrano
fluoro
spiro
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012283449A
Other languages
English (en)
Other versions
AU2012283449A8 (en
AU2012283449A1 (en
Inventor
Michael Gruss
Stefan Kluge
Stefan Pruhs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grünenthal GmbH
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of AU2012283449A1 publication Critical patent/AU2012283449A1/en
Publication of AU2012283449A8 publication Critical patent/AU2012283449A8/en
Application granted granted Critical
Publication of AU2012283449B2 publication Critical patent/AU2012283449B2/en
Priority to AU2017204572A priority Critical patent/AU2017204572B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
AU2012283449A 2011-07-08 2012-07-06 Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine Ceased AU2012283449B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2017204572A AU2017204572B2 (en) 2011-07-08 2017-07-04 Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11005587 2011-07-08
EP11005587.8 2011-07-08
PCT/EP2012/002839 WO2013007361A1 (en) 2011-07-08 2012-07-06 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017204572A Division AU2017204572B2 (en) 2011-07-08 2017-07-04 Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Publications (3)

Publication Number Publication Date
AU2012283449A1 AU2012283449A1 (en) 2014-02-20
AU2012283449A8 AU2012283449A8 (en) 2014-03-27
AU2012283449B2 true AU2012283449B2 (en) 2017-04-06

Family

ID=46717800

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2012283449A Ceased AU2012283449B2 (en) 2011-07-08 2012-07-06 Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
AU2017204572A Ceased AU2017204572B2 (en) 2011-07-08 2017-07-04 Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2017204572A Ceased AU2017204572B2 (en) 2011-07-08 2017-07-04 Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Country Status (23)

Country Link
US (2) US8618156B2 (cg-RX-API-DMAC10.html)
EP (2) EP2729470B1 (cg-RX-API-DMAC10.html)
JP (2) JP6276689B2 (cg-RX-API-DMAC10.html)
CN (2) CN106939005A (cg-RX-API-DMAC10.html)
AR (1) AR087081A1 (cg-RX-API-DMAC10.html)
AU (2) AU2012283449B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014000358A2 (cg-RX-API-DMAC10.html)
CA (1) CA2841032C (cg-RX-API-DMAC10.html)
CY (1) CY1120525T1 (cg-RX-API-DMAC10.html)
DK (2) DK2729470T3 (cg-RX-API-DMAC10.html)
EA (1) EA026750B1 (cg-RX-API-DMAC10.html)
ES (1) ES2641299T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20170968T1 (cg-RX-API-DMAC10.html)
HU (1) HUE033043T2 (cg-RX-API-DMAC10.html)
IL (1) IL230331B (cg-RX-API-DMAC10.html)
LT (1) LT2729470T (cg-RX-API-DMAC10.html)
MX (1) MX2014000297A (cg-RX-API-DMAC10.html)
PL (1) PL2729470T3 (cg-RX-API-DMAC10.html)
PT (1) PT2729470T (cg-RX-API-DMAC10.html)
RS (1) RS56343B1 (cg-RX-API-DMAC10.html)
SI (1) SI2729470T1 (cg-RX-API-DMAC10.html)
TW (1) TWI585092B (cg-RX-API-DMAC10.html)
WO (1) WO2013007361A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8618156B2 (en) * 2011-07-08 2013-12-31 Gruenenthal Gmbh Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
CN107427493A (zh) 2015-01-23 2017-12-01 格吕伦塔尔有限公司 用于治疗肝功能受损和/或肾功能受损的受试者的疼痛的Cebranopadol
US20180021304A1 (en) 2015-02-02 2018-01-25 Ratiopharm Gmbh Composition comprising cebranopadol in a dissolved form
MX2018010367A (es) 2016-02-29 2018-12-10 Guenenthal Gmbh Titulacion de cebranopadol.
JP7365073B2 (ja) * 2019-05-21 2023-10-19 ジァンスー フォアフロント ファーマシューティカル カンパニー，リミテッド トレプロスチニルナトリウムの新規な結晶形および製造方法
CN112254496A (zh) * 2020-09-25 2021-01-22 榆林学院 一种煤泥收集装置
WO2024129782A1 (en) 2022-12-12 2024-06-20 Park Therapeutics, Inc. Regimens and compositions useful for alleviating pain
CN122458986A (zh) 2023-02-15 2026-07-24 艾德神经立治疗公司 有用于缓解疼痛的方案和组合物
WO2026035694A1 (en) 2024-08-05 2026-02-12 Adneuris Therapeutics, Inc. Cebranopadol useful for preventing or reducing opioid induced respiratory depression
WO2026161433A1 (en) 2025-01-21 2026-07-30 Adneuris Therapeutics, Inc. Cebranopadol useful for alleviating pain
WO2026161842A1 (en) 2025-01-27 2026-07-30 Adneuris Therapeutics, Inc. Cebranopadol useful for treating pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10252667A1 (de) 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
DE102006033109A1 (de) * 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
DE102006046745A1 (de) 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
EP3459533A1 (en) * 2010-08-04 2019-03-27 Grünenthal GmbH Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
US8618156B2 (en) * 2011-07-08 2013-12-31 Gruenenthal Gmbh Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Also Published As

Publication number Publication date
DK3235821T3 (da) 2020-04-20
CA2841032C (en) 2020-12-15
CY1120525T1 (el) 2019-07-10
EP2729470A1 (en) 2014-05-14
JP2017081981A (ja) 2017-05-18
MX2014000297A (es) 2014-01-31
CA2841032A1 (en) 2013-01-17
HUE033043T2 (hu) 2017-11-28
SI2729470T1 (sl) 2017-10-30
US20130012563A1 (en) 2013-01-10
JP6559165B2 (ja) 2019-08-14
EP3235821B1 (en) 2020-04-08
ES2641299T3 (es) 2017-11-08
WO2013007361A8 (en) 2013-04-04
HRP20170968T1 (hr) 2017-09-22
DK2729470T3 (en) 2017-09-11
TW201311694A (zh) 2013-03-16
US20130231381A1 (en) 2013-09-05
PT2729470T (pt) 2017-10-02
EP3235821A1 (en) 2017-10-25
BR112014000358A2 (pt) 2017-01-10
US8618156B2 (en) 2013-12-31
AU2012283449A8 (en) 2014-03-27
JP6276689B2 (ja) 2018-02-07
RS56343B1 (sr) 2017-12-29
CN103649094B (zh) 2017-05-24
WO2013007361A9 (en) 2013-12-27
AR087081A1 (es) 2014-02-12
WO2013007361A1 (en) 2013-01-17
PL2729470T3 (pl) 2017-11-30
US8765800B2 (en) 2014-07-01
AU2017204572A1 (en) 2017-07-27
TWI585092B (zh) 2017-06-01
CN106939005A (zh) 2017-07-11
JP2014518226A (ja) 2014-07-28
AU2017204572B2 (en) 2018-05-24
EA201400120A1 (ru) 2014-06-30
LT2729470T (lt) 2017-08-25
EA026750B1 (ru) 2017-05-31
CN103649094A (zh) 2014-03-19
IL230331B (en) 2018-11-29
EP2729470B1 (en) 2017-06-21
AU2012283449A1 (en) 2014-02-20

Similar Documents

Publication Publication Date Title
AU2017204572B2 (en) Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
US8614245B2 (en) Crystalline (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine
AU2012350762B2 (en) Solid forms of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine hydrochloride
AU2012350763B2 (en) Solid forms of (1r,4r)-6'-fluoro-(N,N-dimethyl)-4-phenyl-4',9'-dihydro-3'H-spiro-[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and sulfuric acid
HK1195900A (en) Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
HK1195900B (en) Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
HK1199258B (en) Solid forms of (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine hydrochloride

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 28 , NO 7 , PAGE(S) 962 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME GRUNENTHAL GMBH, APPLICATION NO.2012283449, UNDER INID (54) CORRECT THE TITLE TO READ CRYSTALLINE (1R,4R)-6'-FLUORO-N,N-DIMETHYL-4-PHENYL-4',9'- DIHYDRO-3'H-SPIRO(CYCLOHEXANE-1,1'-PYRANO(3,4,B)INDOL)-4-AMINE

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired